THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.clatterbridgecc.nhs.uk/

Clinical Trials

A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2

Completed

Conditions: Metastatic Uveal Melanoma

Interventions: Drug: Sunitinib
Drug: Dacarbazine

First Posted Date: 2012-03-12

Last Posted Date: 2019-10-29

Lead Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust

Target Recruit Count: 124

Registration Number: NCT01551459

Locations: 🇬🇧
Clatterbridge Centre for Oncology NHS Foundation Trust, Wirral, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy